A nonpolynomial Schroedinger equation for resonantly absorbing gratings

We derive a nonlinear Schroedinger equation with a radical term, in the form of the square root of (1-|V|^2), as an asymptotic model of the optical medium built as a periodic set of thin layers of two-level atoms, resonantly interacting with the electromagnetic field and inducing the Bragg reflection. A family of bright solitons is found, which splits into stable and unstable parts, exactly obeying the Vakhitov-Kolokolov criterion. The soliton with the largest amplitude, which is |V| = 1, is found in an explicit analytical form. It is a "quasi-peakon", with a discontinuity of the third derivative at the center. Families of exact cnoidal waves, built as periodic chains of quasi-peakons, are found too. The ultimate solution belonging to the family of dark solitons, with the background level |V| = 1, is a dark compacton, also obtained in an explicit analytical form. Those bright solitons which are unstable destroy themselves (if perturbed) attaining the critical amplitude, |V| = 1. The dynamics of the wave field around this critical point is studied analytically, revealing a switch of the system into an unstable phase. Collisions between bright solitons are investigated too. The collisions between fast solitons are quasi-elastic, while slowly moving ones merge into breathers, which may persist or perish (in the latter case, also by attaining |V| = 1).Comment: Physical Review A, in pres

Organisms in a changing world

Since its foundation in 1999 by Lawrence Hightower, the Cell Stress Society International (CSSI) has actively promoted international collaboration in the field of stress research. Over the years, the Society has gone from strength to strength, with one of its main, and highly, visible outputs being the journal ‘Cell Stress & Chaperones’. Although initially, the full title of the journal was ‘Cell Stress & Chaperones: An Integrative Journal of Stress Biology and Medicine’ with an emphasis on the medical feld, original scientifc articles were always welcomed from a wide range of organisms and diferent aspects of stress molecular biology. However, in 2020, the sub-title was expanded to ‘An Integrative Journal of Stress Biology, Medicine and the Environment’, in acknowledgement of the increasing importance of understanding the cellular stress response in nonmodel environmental species in the context of the current climate crisis. Initial plans to celebrate the change in subtitle with a special environmental issue were somewhat stymied by the COVID-19 pandemic. However, fnally, 3 years later, we are proud to present this special issue ‘Organisms in a Changing Environment’, which highlights the wide variety of stress response research being carried out in environmental species. In particular, these studies demonstrate how important it is to understand not only the environmental cellular stress response but also their integration with higher levels of biological organisation to understand future biodiversity, and inform conservation measures and policy in our changing world

Hyperfine Spectroscopy of Optically Trapped Atoms

We perform spectroscopy on the hyperfine splitting of $^{85}$Rb atoms trapped in far-off-resonance optical traps. The existence of a spatially dependent shift in the energy levels is shown to induce an inherent dephasing effect, which causes a broadening of the spectroscopic line and hence an inhomogeneous loss of atomic coherence at a much faster rate than the homogeneous one caused by spontaneous photon scattering. We present here a number of approaches for reducing this inhomogeneous broadening, based on trap geometry, additional laser fields, and novel microwave pulse sequences. We then show how hyperfine spectroscopy can be used to study quantum dynamics of optically trapped atoms.Comment: Review/Tutoria

Separating Agent-Functioning and Inter-Agent Coordination by Activated Modules: The DECOMAS Architecture

The embedding of self-organizing inter-agent processes in distributed software applications enables the decentralized coordination system elements, solely based on concerted, localized interactions. The separation and encapsulation of the activities that are conceptually related to the coordination, is a crucial concern for systematic development practices in order to prepare the reuse and systematic integration of coordination processes in software systems. Here, we discuss a programming model that is based on the externalization of processes prescriptions and their embedding in Multi-Agent Systems (MAS). One fundamental design concern for a corresponding execution middleware is the minimal-invasive augmentation of the activities that affect coordination. This design challenge is approached by the activation of agent modules. Modules are converted to software elements that reason about and modify their host agent. We discuss and formalize this extension within the context of a generic coordination architecture and exemplify the proposed programming model with the decentralized management of (web) service infrastructures

Models and algorithms for energy-efficient scheduling with immediate start of jobs

We study a scheduling model with speed scaling for machines and the immediate start requirement for jobs. Speed scaling improves the system performance, but incurs the energy cost. The immediate start condition implies that each job should be started exactly at its release time. Such a condition is typical for modern Cloud computing systems with abundant resources. We consider two cost functions, one that represents the quality of service and the other that corresponds to the cost of running. We demonstrate that the basic scheduling model to minimize the aggregated cost function with n jobs is solvable in O(nlogn) time in the single-machine case and in O(n²m) time in the case of m parallel machines. We also address additional features, e.g., the cost of job rejection or the cost of initiating a machine. In the case of a single machine, we present algorithms for minimizing one of the cost functions subject to an upper bound on the value of the other, as well as for finding a Pareto-optimal solution

Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells

Background: Glioblastoma (GBM), the most malignant primary brain tumor, leads to poor and unpredictable clinical outcomes. Recent studies showed the tumor microenvironment has a critical role in regulating tumor growth by establishing a complex network of interactions with tumor cells. In this context, we investigated how GBM cells modulate resident glial cells, particularly their paracrine activity, and how this modulation can influence back on the malignant phenotype of GBM cells. Methods: Conditioned media (CM) of primary mouse glial cultures unexposed (unprimed) or exposed (primed) to the secretome of GL261 GBM cells were analyzed by proteomic analysis. Additionally, these CM were used in GBM cells to evaluate their impact in glioma cell viability, migration capacity and activation of tumor-related intracellular pathways. Results: The proteomic analysis revealed that the pre-exposure of glial cells to CM from GBM cells led to the upregulation of several proteins related to inflammatory response, cell adhesion and extracellular structure organization within the secretome of primed glial cells. At the functional levels, CM derived from unprimed glial cells favored an increase in GBM cell migration capacity, while CM from primed glial cells promoted cells viability. These effects on GBM cells were accompanied by activation of particular intracellular cancer-related pathways, mainly the MAPK/ERK pathway, which is a known regulator of cell proliferation. Conclusions: Together, our results suggest that glial cells can impact on the pathophysiology of GBM tumors, and that the secretome of GBM cells is able to modulate the secretome of neighboring glial cells, in a way that regulates the "go-or-grow" phenotypic switch of GBM cells.Fundação para a Ciência e Tecnologia (IF/00601/2012 to B.M.C.; IF/00111 to A.J.S; SFRH/BD/52287/2013 to A.I.O.; SFRH/BD/81495/2011 to S.I.A.; SFRH/BD/88121/2012 to J.V.C.; projects PTDC/SAU-GMG/113795/2009 to B.M.C.; PTDC/NEU-NMC/0205/2012, PTDC/NEU-SCC/7051/2014, PEst-C/SAU/LA0001/2013–2014 and UID/NEU/04539/2013 to B.M.), Liga Portuguesa Contra o Cancro (B.M.C.), Fundação Calouste Gulbenkian (B.M.C.) and Inter-University Doctoral Programme in Ageing and Chronic Disease (PhDOC; to A.I.O.). Project co-financed by Programa Operacional Regional do Norte (ON.2—O Novo Norte), Quadro de Referência Estratégico Nacional (QREN), Fundo Europeu de Desenvolvimento Regional (FEDER), Programa Operacional Factores de Competitividade (COMPETE), and by The National Mass Spectrometry Network (RNEM) under the contract REDE/1506/REM/2005info:eu-repo/semantics/publishedVersio

Anti-proliferative effect of Rosmarinus officinalis L. extract on human melanoma A375 cells

Rosemary (Rosmarinus officinalis L.) has been used since ancient times in traditional medicine, while nowadays various rosemary formulations are increasingly exploited by alternative medicine to cure or prevent a wide range of health disorders. Rosemary's bioproperties have prompted scientific investigation, which allowed us to ascertain antioxidant, anti-inflammatory, cytostatic, and cytotoxic activities of crude extracts or of pure components. Although there is a growing body of experimental work, information about rosemary's anticancer properties, such as chemoprotective or anti-proliferative effects on cancer cells, is very poor, especially concerning the mechanism of action. Melanoma is a skin tumor whose diffusion is rapidly increasing in the world and whose malignancy is reinforced by its high resistance to cytotoxic agents; hence the availability of new cytotoxic drugs would be very helpful to improve melanoma prognosis. Here we report on the effect of a rosemary hydroalcoholic extract on the viability of the human melanoma A375 cell line. Main components of rosemary extract were identified by liquid chromatography coupled to tandem mass spectrometry (LC/ESI-MS/MS) and the effect of the crude extract or of pure components on the proliferation of cancer cells was tested by MTT and Trypan blue assays. The effect on cell cycle was investigated by using flow cytometry, and the alteration of the cellular redox state was evaluated by intracellular ROS levels and protein carbonylation analysis. Furthermore, in order to get information about the molecular mechanisms of cytotoxicity, a comparative proteomic investigation was performed

Intravascular ultrasound pulmonary artery denervation to treat pulmonary arterial hypertension (TROPHY1)

Objectives The aim of this study was to investigate whether therapeutic intravascular ultrasound pulmonary artery denervation (PDN) is safe and reduces pulmonary vascular resistance (PVR) in patients with pulmonary arterial hypertension (PAH) on a minimum of dual oral therapy. Background Early studies have suggested that PDN can reduce PVR in patients with PAH. Methods TROPHY1 (Treatment of Pulmonary Hypertension 1) was a multicenter, international, open-label trial undertaken at 8 specialist centers. Patients 18 to 75 years of age with PAH were eligible if taking dual oral or triple nonparenteral therapy and not responsive to acute vasodilator testing. Eligible patients underwent PDN (TIVUS System). The primary safety endpoint was procedure-related adverse events at 30 days. Secondary endpoints included procedure-related adverse events, disease worsening and death to 12 months, and efficacy endpoints that included change in pulmonary hemodynamic status, 6-min walk distance, and quality of life from baseline to 4 or 6 months. Patients were to remain on disease-specific medication for the duration of the study. Results Twenty-three patients underwent PDN, with no procedure-related serious adverse events reported. The reduction in PVR at 4- or 6-month follow-up was 94 ± 151 dyn·s·cm−5 (p = 0.001) or 17.8%, which was associated with a 42 ± 63 m (p = 0.02) increase in 6-min walk distance and a 671 ± 1,555 step (p = 0.04) increase in daily activity. Conclusions In this multicenter early feasibility study, PDN with an intravascular ultrasound catheter was performed without procedure-related adverse events and was associated with a reduction in PVR and increases in 6-min walk distance and daily activity in patients with PAH on background dual or triple therapy